Contrast Nephropathy Features

Physician Polls Are statins a valid approach for preventing contrast-induced nephropathy (CIN)?

Are statins a valid approach for preventing contrast-induced nephropathy (CIN)?

Patients treated with statins have a significant 55% decreased odds of contrast-induced nephropathy.

World Literature Review

Low-Osmolar Contrast Agent Is Safer For the Kidneys

A large Swedish study of patients undergoing coronary procedures shows that renal failure is more likely to develop with the use of an iso-osmolar rather than low-osmolar contrast media.

Latest Contrast Nephropathy News

Contrast Nephropathy Associated with Long-Term Mortality in CKD

Contrast Nephropathy Associated with Long-Term Mortality in CKD

Increased long-term mortality risk for patients with, but not those without, chronic kidney disease.

Contrast-Induced Nephropathy Risk Minimal

Contrast-Induced Nephropathy Risk Minimal

Researchers found no statistically significant incidence of CIN in a study of 2,277 patients who had a total of 2,583 CT scans with contrast.

Contrast-Induced Nephropathy Risk Lowered with ED Drug

Contrast-Induced Nephropathy Risk Lowered with ED Drug

In a study of patients undergoing coronary procedures, the incidence of CIN was 2.7% alprostadl recipients versus 11.1% of controls.

Contrast-Induced Nephropathy Risk Cut by Nitrates

Contrast-Induced Nephropathy Risk Cut by Nitrates

The condition was 67% less likely to develop in patients who received a nitrate before percutaneous coronary intervention.

Ascorbic Acid Does Not Lower Contrast-Induced Nephropathy Risk

It might decrease the likelihood of renal function decline, however.

Predictor of Contrast-Induced Nephropathy Identified

Predictor of Contrast-Induced Nephropathy Identified

Contrast volume:eGFR ratio may be useful in calculating the maximum amount of contrast to give.

BP Drugs Could Boost Risk of Contrast-Induced AKI

Use of ACE inhibitors and angiotensin receptor blockers during coronary angiography found to independently boost risk by 43%.

Hyponatremia May Predict Contrast-Induced Nephropathy

PRAGUE—Transient hyponatremia may precede development of contrast-induced nephropathy (CIN) in patients undergoing coronary angiography, according to investigators.

Study: Women Are At Higher Risk of RCIN

LAS VEGAS—Women with an estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m2 or higher are at higher risk than men for experiencing radiocontrast-induced nephropathy (RCIN) following coronary angiography, investigators reported at the National Kidney Foundation's Spring Clinical Meetings.

Drug Offers No CIN Protection

CHICAGO—Brazilian researchers report that acetylcysteine should no longer be used to prevent contrast-induced nephropathy (CIN) in patients undergoing coronary and vascular angiography.

CIN Prevention Strategies Similarly Effective

Researchers find no difference between saline and sodium bicarbonate.

High Incidence of Contrast-Induced Nephropathy Found

Contrast-induced nephropathy (CIN) develops in 11% of emergency department patients who undergo contrast-enhanced CT (CECT).

Sodium Bicarbonate Does Not Decrease CIN Risk

A recent study shows that sodium bicarbonate is no better than saline in preventing contrast-induced nephropathy (CIN).

CIN May Have a Causal Role in Long-Term Adverse Events

Evidence comes from a study comparing two strategies for preventing contrast-induced nephropathy

Trial for Fluid Replacement System and CIN Prevention

PLC Medical Systems, Inc., of Franklin, Mass., has received full approval for a U.S. pivotal trial to study the effectiveness of its RenalGuard System and associated therapy in the prevention of contrast-induced nephropathy (CIN).